Related Experiment Video
Updated: Aug 5, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
4-Bromomethcathinone (4-BMC) Revisited: The First Reported Fatal Case and Toxicological Insights
Karolina Nowak1, Paweł Szpot2, Marcin Zawadzki3
1Department of Pharmacology, Faculty of Medicine, University of Opole, 48 Oleska Street, 45052 Opole, Poland.
This study reports the first fatal intoxication case involving 4-bromomethcathinone (4-BMC), a substance recently resurging in Europe. High concentrations of 4-BMC and 3-chloromethcathinone were detected in post-mortem samples, highlighting the need for increased toxicological monitoring.
Area of Science:
- Forensic Toxicology
- Clinical Toxicology
- Pharmacovigilance
Background:
- 4-bromomethcathinone (4-BMC) has been detected on the illicit drug market since 2011.
- Recent data show a resurgence of 4-BMC availability in Europe, with significant seizures in 2024.
- This paper details the world's first reported fatal intoxication case involving 4-BMC.
Purpose of the Study:
- To document and analyze the first fatal intoxication case involving 4-bromomethcathinone (4-BMC).
- To quantify 4-BMC and co-occurring substances in post-mortem biological samples.
- To emphasize the need for enhanced monitoring of emerging and re-emerging psychoactive substances.
Main Methods:
- Quantitative analysis of 4-BMC in post-mortem blood and urine using Ultra-High Performance Liquid Chromatography coupled with Triple Quadrupole Mass Spectrometry (UHPLC-QqQ-MS/MS).
- Complementary toxicological analyses were performed.
- Screening for other drugs, medications, and new psychoactive substances.
Main Results:
- Detected 4-BMC concentrations of 16,601 ng/mL in blood and over 50,000 ng/mL in urine.
- Identified 3-chloromethcathinone in blood (1.7 ng/mL) and urine (122.2 ng/mL).
- No other xenobiotics were detected besides 4-BMC and 3-chloromethcathinone.
Conclusions:
- This case highlights the potential lethality of 4-BMC and the need for increased vigilance by forensic and clinical toxicologists.
- The re-emergence of 4-BMC underscores the dynamic nature of the illicit drug market and the persistent threat of previously known substances.
- Enhanced monitoring strategies are crucial for public health and safety in response to evolving xenobiotic threats.
Related Concept Videos
Toxidromes: Clinical Features
Physical Properties of Amines
Pharmaceutical Poisoning: Potential Scenarios
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Drug Toxicity: Overview
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

